Health
Effective treatment for hot flashes
NEWS IN BRIEF — Posted July 24, 2006
The drug gabapentin -- marketed as Neurontin -- appeared to be as effective as estrogen in helping to tame hot flashes in postmenopausal women, according to a study published in the July Obstetrics and Gynecology.
University of Rochester (N.Y.) researchers compared the effectiveness of gabapentin and estrogen with a placebo in a 12-week, randomized, double-blind trial with 60 female participants. The women recorded the frequency and severity of their hot flashes in diaries.
"Gabapentin does appear to be as effective as estrogen," said lead author Sireesha Y. Reddy, MD, assistant professor of obstetrics and gynecology at the University of Rochester Medical Center. "Until now its efficacy relative to estrogen was unknown."
Estrogen had been the gold standard treatment for vasomotor symptoms but fell from favor when early results of the Women's Health Initiative in 2002 showed that the hormone posed an increased risk for heart attacks, strokes and breast cancer.
The women taking gabapentin and estrogen reported a 71% to 72% reduction in hot flashes over the course of the study.
Those taking the placebo also reported a decrease in hot flashes, although it was only a 54% reduction.
Gabapentin was approved by the Food and Drug Administration in 1994 to treat epileptic seizures but has been used off-label to treat headaches, shingles pain and other ailments. Scientists hypothesize that the drug may reduce hot flashes by regulating the flow of calcium in and out of cells, which is one mechanism for controlling body temperatures.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/07/24/hlbf0724.htm.












